Amoxicillin-Clavulanate Dosing Guidelines
Adult Dosing
For adults with respiratory tract infections and normal renal function, prescribe amoxicillin-clavulanate 875 mg/125 mg twice daily for 5–7 days as the standard regimen. 1
Standard-Dose Regimen (Low-Risk Patients)
- 875 mg/125 mg twice daily for 5–7 days achieves clinical cure rates of 88–93% in uncomplicated respiratory infections. 1, 2
- Alternative: 500 mg/125 mg three times daily for 7–10 days, though twice-daily dosing improves adherence. 1, 3
- A 5–7 day course is as effective as 10 days for acute bacterial rhinosinusitis and produces fewer adverse effects. 1
High-Dose Regimen (Patients with Resistance Risk Factors)
2000 mg/125 mg twice daily for 5–7 days when any of these factors are present: 1, 4
- Recent antibiotic use (past 4–6 weeks)
- Age > 65 years
- Moderate-to-severe infection
- Comorbidities (diabetes, chronic cardiac/pulmonary/renal/hepatic disease)
- Immunocompromised status
- Smoking or exposure to smokers
- Daycare contact or healthcare environment exposure
- Community prevalence of penicillin-resistant S. pneumoniae > 10%
- Frontal or sphenoidal sinusitis
- History of recurrent infections or prior treatment failure
High-dose therapy achieves 90–92% predicted clinical efficacy versus 83–88% for standard dosing in resistance-risk populations. 1, 4
This regimen eradicates S. pneumoniae strains with amoxicillin MICs up to 4–8 mg/L. 4
Intravenous Dosing (Severe Infections)
- 1.2 g (1000 mg amoxicillin/200 mg clavulanate) every 6–8 hours for hospitalized patients with severe pneumonia or intra-abdominal infections. 4, 5
- Switch to oral therapy (625 mg three times daily or 875 mg twice daily) as soon as clinically appropriate. 1, 4
Pediatric Dosing (≥ 3 Months, < 40 kg)
For children with respiratory infections, prescribe high-dose amoxicillin-clavulanate 90 mg/kg/day (amoxicillin component) + 6.4 mg/kg/day (clavulanate) divided twice daily for 10–14 days as first-line therapy. 1, 4
High-Dose Regimen (First-Line for Most Infections)
- 90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate divided into 2 doses daily for 10–14 days. 1, 4
- Maximum daily dose: 4000 mg amoxicillin. 4, 5
- This 14:1 ratio formulation causes less diarrhea than older preparations. 1
Indications for High-Dose Pediatric Therapy
Use high-dose regimen when any of these factors are present: 1, 4
- Age < 2 years
- Daycare attendance
- Recent antibiotic use (past 30 days)
- Incomplete Haemophilus influenzae type b vaccination
- Regional penicillin-resistant S. pneumoniae prevalence > 10%
- Moderate-to-severe illness
- Concurrent purulent otitis media or conjunctivitis
- Pneumonia not responding to amoxicillin alone
Standard-Dose Regimen (Uncomplicated Cases Only)
- 45 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate divided twice daily for 10–14 days. 1, 4
- Use only for mild, uncomplicated infections in children without risk factors. 1
Intravenous Pediatric Dosing
- 30 mg/kg (amoxicillin component) every 8 hours for moderate infections. 4, 5
- 200 mg/kg/day divided every 6 hours for severe infections or when undrained abscesses are suspected. 5
- Administer as IV infusion over 15–30 minutes. 5
Patients ≥ 40 kg
- Dose as adults (875 mg/125 mg twice daily or 2000 mg/125 mg twice daily), not using pediatric weight-based calculations. 1
Renal Impairment Dosing Adjustments
In patients with renal impairment, reduce dosing frequency or total daily dose based on creatinine clearance to prevent drug accumulation. 4, 6
Adults with Renal Dysfunction
- CrCl 10–30 mL/min: Reduce frequency to every 12 hours OR decrease dose by 50%. 4
- CrCl < 10 mL/min: Reduce frequency to every 24 hours OR decrease dose by 75%. 4
- Hemodialysis: Administer supplemental dose after each dialysis session. 4, 7
- Amoxicillin half-life increases from 71 minutes (normal renal function) to 16 hours in anephric patients. 6
Pediatric Renal Impairment
- Apply proportional dose reductions based on estimated creatinine clearance, mirroring adult adjustments. 4
- Specific pediatric renal dosing data are limited; consult infectious disease specialist for severe impairment. 4
Patients on Renal Replacement Therapy
- In critically ill patients receiving continuous RRT, consider 2.2 g every 6–8 hours with therapeutic drug monitoring, as RRT significantly increases clearance even with normal native kidney function. 7
Clinical Reassessment and Treatment Failure
Adults
- Reassess at 3–5 days: If no improvement, escalate to high-dose amoxicillin-clavulanate (2000 mg/125 mg twice daily) or switch to a respiratory fluoroquinolone. 1
- Reassess at 7 days: Persistent or worsening symptoms require diagnostic reconsideration, imaging (CT scan), and possible ENT referral. 1, 4
Children
- Reassess at 72 hours: Lack of improvement or clinical worsening warrants escalation to high-dose regimen (90 mg/kg/day). 1, 4
- Expect clinical improvement within 48–72 hours; if absent, reevaluate diagnosis and consider alternative pathogens. 5
Common Pitfalls and Caveats
- Avoid antibiotics for symptom duration < 10 days unless severe features are present (fever ≥ 39°C with purulent nasal discharge for ≥ 3 consecutive days); 98–99.5% of acute rhinosinusitis cases are viral. 1
- Do not underdose in high-resistance areas: Always use high-dose formulations (2000 mg/125 mg twice daily for adults or 90 mg/kg/day for children) when community penicillin-resistant S. pneumoniae prevalence exceeds 10%. 1, 4
- Minimum treatment duration: ≥ 5 days for adults and ≥ 10 days for children to reduce relapse risk. 1
- Gastrointestinal adverse events occur in 15–40% of patients but rarely require discontinuation. 4
- Verify weight-based calculations in pediatric patients to prevent dosing errors. 5
- Do not use for MRSA coverage: Amoxicillin-clavulanate covers methicillin-sensitive S. aureus only; routine MRSA coverage is not recommended for initial empiric therapy of acute bacterial rhinosinusitis. 1
Adjunctive Therapies
- Intranasal corticosteroids (mometasone, fluticasone, budesonide) twice daily reduce mucosal inflammation and accelerate symptom resolution. 1
- Saline nasal irrigation 2–3 times daily enhances mucus clearance and provides symptomatic relief. 1
- Analgesics (acetaminophen or ibuprofen) for pain and fever control. 1